Cargando…
Mesenchymal Stromal Cells Are More Effective Than Their Extracellular Vesicles at Reducing Lung Injury Regardless of Acute Respiratory Distress Syndrome Etiology
Although mesenchymal stromal cells (MSCs) have demonstrated beneficial effects on experimental acute respiratory distress syndrome (ARDS), preconditioning may be required to potentiate their therapeutic effects. Additionally, administration of cell-free products, such as extracellular vesicles (EVs)...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6720722/ https://www.ncbi.nlm.nih.gov/pubmed/31531026 http://dx.doi.org/10.1155/2019/8262849 |
_version_ | 1783448191659671552 |
---|---|
author | Silva, Johnatas D. de Castro, Ligia L. Braga, Cassia L. Oliveira, Gisele P. Trivelin, Stefano A. Barbosa-Junior, Carlos M. Morales, Marcelo M. dos Santos, Claudia C. Weiss, Daniel J. Lopes-Pacheco, Miquéias Cruz, Fernanda F. Rocco, Patricia R. M. |
author_facet | Silva, Johnatas D. de Castro, Ligia L. Braga, Cassia L. Oliveira, Gisele P. Trivelin, Stefano A. Barbosa-Junior, Carlos M. Morales, Marcelo M. dos Santos, Claudia C. Weiss, Daniel J. Lopes-Pacheco, Miquéias Cruz, Fernanda F. Rocco, Patricia R. M. |
author_sort | Silva, Johnatas D. |
collection | PubMed |
description | Although mesenchymal stromal cells (MSCs) have demonstrated beneficial effects on experimental acute respiratory distress syndrome (ARDS), preconditioning may be required to potentiate their therapeutic effects. Additionally, administration of cell-free products, such as extracellular vesicles (EVs) obtained from MSC-conditioned media, might be as effective as MSCs. In this study, we comparatively evaluated the effects of MSCs, preconditioned or not with serum collected from mice with pulmonary or extrapulmonary ARDS (ARDSp and ARDSexp, respectively), and the EVs derived from these cells on lung inflammation and remodeling in ARDSp and ARDSexp mice. Administration of MSCs (preconditioned or not), but not their EVs, reduced static lung elastance, interstitial edema, and collagen fiber content in both ARDSp and ARDSexp. Although MSCs and EVs reduced alveolar collapse and neutrophil cell counts in lung tissue, therapeutic responses were superior in mice receiving MSCs, regardless of preconditioning. Despite higher total cell, macrophage, and neutrophil counts in bronchoalveolar lavage fluid in ARDSp than ARDSexp, MSCs and EVs (preconditioned or not) led to a similar decrease. In ARDSp, both MSCs and EVs, regardless of preconditioning, reduced levels of tumor necrosis factor- (TNF-) α, interleukin-6, keratinocyte chemoattractant (KC), vascular endothelial growth factor (VEGF), and transforming growth factor- (TGF-) β in lung homogenates. In ARDSexp, TNF-α, interleukin-6, and KC levels were reduced by MSCs and EVs, preconditioned or not; only MSCs reduced VEGF levels, while TGF-β levels were similarly increased in ARDSexp treated either with saline, MSCs, or EVs, regardless of preconditioning. In conclusion, MSCs yielded greater overall improvement in ARDS in comparison to EVs derived from the same number of cells and regardless of the preconditioning status. However, the effects of MSCs and EVs differed according to ARDS etiology. |
format | Online Article Text |
id | pubmed-6720722 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-67207222019-09-17 Mesenchymal Stromal Cells Are More Effective Than Their Extracellular Vesicles at Reducing Lung Injury Regardless of Acute Respiratory Distress Syndrome Etiology Silva, Johnatas D. de Castro, Ligia L. Braga, Cassia L. Oliveira, Gisele P. Trivelin, Stefano A. Barbosa-Junior, Carlos M. Morales, Marcelo M. dos Santos, Claudia C. Weiss, Daniel J. Lopes-Pacheco, Miquéias Cruz, Fernanda F. Rocco, Patricia R. M. Stem Cells Int Research Article Although mesenchymal stromal cells (MSCs) have demonstrated beneficial effects on experimental acute respiratory distress syndrome (ARDS), preconditioning may be required to potentiate their therapeutic effects. Additionally, administration of cell-free products, such as extracellular vesicles (EVs) obtained from MSC-conditioned media, might be as effective as MSCs. In this study, we comparatively evaluated the effects of MSCs, preconditioned or not with serum collected from mice with pulmonary or extrapulmonary ARDS (ARDSp and ARDSexp, respectively), and the EVs derived from these cells on lung inflammation and remodeling in ARDSp and ARDSexp mice. Administration of MSCs (preconditioned or not), but not their EVs, reduced static lung elastance, interstitial edema, and collagen fiber content in both ARDSp and ARDSexp. Although MSCs and EVs reduced alveolar collapse and neutrophil cell counts in lung tissue, therapeutic responses were superior in mice receiving MSCs, regardless of preconditioning. Despite higher total cell, macrophage, and neutrophil counts in bronchoalveolar lavage fluid in ARDSp than ARDSexp, MSCs and EVs (preconditioned or not) led to a similar decrease. In ARDSp, both MSCs and EVs, regardless of preconditioning, reduced levels of tumor necrosis factor- (TNF-) α, interleukin-6, keratinocyte chemoattractant (KC), vascular endothelial growth factor (VEGF), and transforming growth factor- (TGF-) β in lung homogenates. In ARDSexp, TNF-α, interleukin-6, and KC levels were reduced by MSCs and EVs, preconditioned or not; only MSCs reduced VEGF levels, while TGF-β levels were similarly increased in ARDSexp treated either with saline, MSCs, or EVs, regardless of preconditioning. In conclusion, MSCs yielded greater overall improvement in ARDS in comparison to EVs derived from the same number of cells and regardless of the preconditioning status. However, the effects of MSCs and EVs differed according to ARDS etiology. Hindawi 2019-08-21 /pmc/articles/PMC6720722/ /pubmed/31531026 http://dx.doi.org/10.1155/2019/8262849 Text en Copyright © 2019 Johnatas D. Silva et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Silva, Johnatas D. de Castro, Ligia L. Braga, Cassia L. Oliveira, Gisele P. Trivelin, Stefano A. Barbosa-Junior, Carlos M. Morales, Marcelo M. dos Santos, Claudia C. Weiss, Daniel J. Lopes-Pacheco, Miquéias Cruz, Fernanda F. Rocco, Patricia R. M. Mesenchymal Stromal Cells Are More Effective Than Their Extracellular Vesicles at Reducing Lung Injury Regardless of Acute Respiratory Distress Syndrome Etiology |
title | Mesenchymal Stromal Cells Are More Effective Than Their Extracellular Vesicles at Reducing Lung Injury Regardless of Acute Respiratory Distress Syndrome Etiology |
title_full | Mesenchymal Stromal Cells Are More Effective Than Their Extracellular Vesicles at Reducing Lung Injury Regardless of Acute Respiratory Distress Syndrome Etiology |
title_fullStr | Mesenchymal Stromal Cells Are More Effective Than Their Extracellular Vesicles at Reducing Lung Injury Regardless of Acute Respiratory Distress Syndrome Etiology |
title_full_unstemmed | Mesenchymal Stromal Cells Are More Effective Than Their Extracellular Vesicles at Reducing Lung Injury Regardless of Acute Respiratory Distress Syndrome Etiology |
title_short | Mesenchymal Stromal Cells Are More Effective Than Their Extracellular Vesicles at Reducing Lung Injury Regardless of Acute Respiratory Distress Syndrome Etiology |
title_sort | mesenchymal stromal cells are more effective than their extracellular vesicles at reducing lung injury regardless of acute respiratory distress syndrome etiology |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6720722/ https://www.ncbi.nlm.nih.gov/pubmed/31531026 http://dx.doi.org/10.1155/2019/8262849 |
work_keys_str_mv | AT silvajohnatasd mesenchymalstromalcellsaremoreeffectivethantheirextracellularvesiclesatreducinglunginjuryregardlessofacuterespiratorydistresssyndromeetiology AT decastroligial mesenchymalstromalcellsaremoreeffectivethantheirextracellularvesiclesatreducinglunginjuryregardlessofacuterespiratorydistresssyndromeetiology AT bragacassial mesenchymalstromalcellsaremoreeffectivethantheirextracellularvesiclesatreducinglunginjuryregardlessofacuterespiratorydistresssyndromeetiology AT oliveiragiselep mesenchymalstromalcellsaremoreeffectivethantheirextracellularvesiclesatreducinglunginjuryregardlessofacuterespiratorydistresssyndromeetiology AT trivelinstefanoa mesenchymalstromalcellsaremoreeffectivethantheirextracellularvesiclesatreducinglunginjuryregardlessofacuterespiratorydistresssyndromeetiology AT barbosajuniorcarlosm mesenchymalstromalcellsaremoreeffectivethantheirextracellularvesiclesatreducinglunginjuryregardlessofacuterespiratorydistresssyndromeetiology AT moralesmarcelom mesenchymalstromalcellsaremoreeffectivethantheirextracellularvesiclesatreducinglunginjuryregardlessofacuterespiratorydistresssyndromeetiology AT dossantosclaudiac mesenchymalstromalcellsaremoreeffectivethantheirextracellularvesiclesatreducinglunginjuryregardlessofacuterespiratorydistresssyndromeetiology AT weissdanielj mesenchymalstromalcellsaremoreeffectivethantheirextracellularvesiclesatreducinglunginjuryregardlessofacuterespiratorydistresssyndromeetiology AT lopespachecomiqueias mesenchymalstromalcellsaremoreeffectivethantheirextracellularvesiclesatreducinglunginjuryregardlessofacuterespiratorydistresssyndromeetiology AT cruzfernandaf mesenchymalstromalcellsaremoreeffectivethantheirextracellularvesiclesatreducinglunginjuryregardlessofacuterespiratorydistresssyndromeetiology AT roccopatriciarm mesenchymalstromalcellsaremoreeffectivethantheirextracellularvesiclesatreducinglunginjuryregardlessofacuterespiratorydistresssyndromeetiology |